Camlin Fine Sciences Promoter Pledges Additional 37.50 Lakh Shares to Two Lenders

2 min read     Updated on 15 Apr 2026, 12:40 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences promoter Ashish Subhash Dandekar has pledged an additional 37.50 lakh equity shares to two NBFCs - Aditya Birla Capital Limited and SKS Fincap Private Limited. The pledges, created on April 7-8, 2026, increase total encumbered shareholding to 1.91 crore shares (9.92% of share capital), representing 96.32% of the promoter's total holding.

powered bylight_fuzz_icon
37351647

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences promoter Ashish Subhash Dandekar has pledged additional equity shares to two financial institutions as margin for financial assistance, according to regulatory disclosures filed on April 13, 2026. The pledges were created on April 7 and April 8, 2026, in favor of Aditya Birla Capital Limited and SKS Fincap Private Limited respectively.

Share Pledge Details

The latest encumbrances involve a total of 37.50 lakh equity shares across two separate transactions, representing 1.95% of the company's total share capital. These pledges were created to address security cover requirements for financial assistance obtained by the target company.

Parameter: Transaction 1 Transaction 2
Shares Pledged: 12.50 lakh 25.00 lakh
Percentage of Share Capital: 0.65% 1.30%
Date of Pledge: April 7, 2026 April 8, 2026
Beneficiary: Aditya Birla Capital Limited SKS Fincap Private Limited
Type of Encumbrance: Pledge Pledge
Share Value on Event Date: ₹12.98 crore ₹27.35 crore

Updated Promoter Shareholding Position

Following these transactions, Dandekar's total encumbered shareholding has increased substantially. The promoter maintains a 10.30% stake in the company while using a significant portion as collateral for financial arrangements.

Shareholding Details: Current Position
Total Promoter Holding: 1.98 crore shares (10.30%)
Previously Encumbered: 1.53 crore shares (7.96%)
Additional Pledges: 37.50 lakh shares (1.95%)
Total Encumbered Shares: 1.91 crore shares (9.92%)
Encumbered as % of Promoter Holding: 96.32%

Financial Institution Details

Both beneficiary entities are established financial institutions. Aditya Birla Capital Limited operates as a non-banking financial company (NBFC), while SKS Fincap Private Limited also functions as an NBFC. The second transaction with SKS Fincap involves a borrowing amount of ₹10.00 crore against pledged shares valued at ₹27.35 crore, providing a security cover ratio of 2.73.

Institution Details: Aditya Birla Capital SKS Fincap Private
Entity Type: NBFC NBFC
Amount Involved: Not specified ₹10.00 crore
Security Cover Ratio: Not applicable 2.73
Purpose: Margin pledge for security cover Facilitate company borrowing

Regulatory Compliance Framework

The disclosures were made in compliance with Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The official regulatory filing confirms that while the encumbered shares represent more than 50% of the promoter's shareholding, they constitute less than 20% of the company's total share capital.

Compliance Parameter: Status
Encumbered Share ≥ 50% of Promoter Holding: YES
Encumbered Share ≥ 20% of Total Share Capital: NO
Stock Exchanges Notified: BSE Limited, NSE
Reporting Date: April 13, 2026

Purpose and Utilization

The encumbrances serve specific purposes related to the company's financial requirements. The first pledge with Aditya Birla Capital was created as additional margin for covering shortfall in security cover with respect to financial assistance obtained for acquiring shares of the target company. The second pledge with SKS Fincap was specifically created to facilitate borrowing by the target company, demonstrating the promoter's commitment to supporting the company's capital requirements and operational needs.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.32%+18.62%+20.14%-36.95%-22.16%-17.27%

What impact could the 96.32% encumbrance of promoter holdings have on Camlin Fine Sciences' stock liquidity and investor confidence?

How might this high level of share pledging affect the company's ability to raise equity capital or pursue strategic acquisitions in the future?

What are the potential consequences if Camlin Fine Sciences faces financial stress and the pledged shares need to be invoked by the lenders?

Camlin Fine Sciences Receives ₹5.47 Crore Income Tax Demand Notice for AY 2023-24

1 min read     Updated on 11 Apr 2026, 12:19 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Camlin Fine Sciences Limited has received an income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24 related to transfer pricing adjustments on transactions with Associated Enterprises. The company disclosed this to stock exchanges under SEBI regulations and stated it plans to file an appeal against the order. The company has clarified that there is no immediate impact on its financial or operational activities due to this development.

powered bylight_fuzz_icon
37392579

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences Limited has received a significant income tax demand notice of ₹5,46,98,560 for Assessment Year 2023-24, the company disclosed to stock exchanges on April 10, 2026. The notice was issued under section 156 of the Income-Tax Act, 1961, following an Assessment Order from the Income Tax Department's Assessment Unit.

Details of the Tax Demand

The demand notice requires the company to deposit the specified amount within 30 days of service. The primary reason for this substantial demand relates to transfer pricing adjustments, specifically concerning Arm's Length Price adjustments for international and domestic transactions entered into by the company with its Associated Enterprises.

Parameter Details
Issuing Authority Assessment Unit, Income Tax Department
Demand Amount ₹5,46,98,560
Assessment Year 2023-24
Legal Provision Section 156 of Income-Tax Act, 1961
Payment Timeline 30 days from service date
Receipt Date April 10, 2026

Nature of Assessment

The Assessment Order was issued under section 143(3) of the Income-Tax Act, 1961. The demand primarily stems from adjustments made to the Arm's Length Price regarding the value of transactions between Camlin Fine Sciences and its Associated Enterprises. This indicates that the tax authorities have questioned the pricing of inter-company transactions and made upward adjustments, resulting in additional tax liability.

Company's Response and Impact

Camlin Fine Sciences has stated that there is no immediate impact on the company's financial, operational, or other activities due to this order. The company has examined the assessment order and is currently in the process of filing an appeal against it. This suggests that the company disagrees with the tax authorities' assessment and intends to challenge the demand through the appellate process.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The disclosure was made simultaneously to both BSE Limited and the National Stock Exchange of India Limited, ensuring transparency with all stakeholders regarding this material development.

The disclosure was signed by Rahul Sawale, Company Secretary and VP Legal, indicating the seriousness with which the company is treating this matter and its commitment to proper corporate governance practices.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.32%+18.62%+20.14%-36.95%-22.16%-17.27%

How might this transfer pricing dispute affect Camlin Fine Sciences' future international expansion and subsidiary structuring strategies?

What potential impact could a prolonged appellate process have on the company's cash flow and working capital management?

Will this tax demand prompt increased regulatory scrutiny of transfer pricing practices across the broader chemical and fine sciences industry?

More News on Camlin Fine Sciences

1 Year Returns:-22.16%